VitalRx
    Physician-Supervised Peptide Therapy Β· All 50 StatesSee Peptides

    Clinical Protocol Guide

    CJC-1295 / Ipamorelin: The Complete Guide You've Been Looking For

    No marketing hype. No protocol myths. No units-vs-mcg confusion. Just the most transparent clinical guide we could write.

    Off-Label RxInjectablePhysician-SupervisedAll 50 States
    πŸ›‘οΈ

    Editorial Transparency: This guide cites evidence levels honestly. Where data is weak or absent, we say so.

    Section 01

    What It Actually Is

    CJC-1295 / Ipamorelin is a combination of two peptides that work synergistically to stimulate your body's natural growth hormone (GH) production. CJC-1295 is a growth hormone-releasing hormone (GHRH) analog that extends the GH release window. Ipamorelin is a growth hormone secretagogue that triggers a clean GH pulse without spiking cortisol or prolactin.

    Together, they amplify and sustain the pulsatile release of GH from the anterior pituitary, mimicking your body's natural rhythm rather than replacing it.

    ~30 min

    Ipamorelin half-life

    2–4Γ—

    GH pulse amplification

    90 days

    Minimum protocol

    ⚠️What this stack is NOT

    This is not synthetic HGH. It does not inject growth hormone directly. It stimulates your pituitary to produce more of its own GH. If your pituitary function is severely compromised, this stack may not be effective. It is also not a fat burner, muscle builder, or anti-aging miracle, though patients report improvements in all three areas over time with physician oversight.

    Section 02

    Who It's Actually For

    The most common patient profiles we see fall into four categories. A physician will evaluate your specific health history before prescribing.

    FeatureCJC-1295 (no DAC)CJC-1295 DACIpamorelinCombined Stack
    Half-life~30 min~8 days~30 minSynergistic
    Injection Frequency1–2Γ— daily1–2Γ— weekly1–2Γ— daily1–2Γ— daily
    GH Pulse QualityPulsatileSustainedCleanExcellent
    Side EffectsMinimalGH bleed riskMinimalMinimal
    Most Common UseClinicalConvenienceClinicalGold standard

    Feature

    Half-life

    CJC-1295 (no DAC)

    ~30 min

    CJC-1295 DAC

    ~8 days

    Ipamorelin

    ~30 min

    Combined Stack

    Synergistic

    Feature

    Injection Frequency

    CJC-1295 (no DAC)

    1–2Γ— daily

    CJC-1295 DAC

    1–2Γ— weekly

    Ipamorelin

    1–2Γ— daily

    Combined Stack

    1–2Γ— daily

    Feature

    GH Pulse Quality

    CJC-1295 (no DAC)

    Pulsatile

    CJC-1295 DAC

    Sustained

    Ipamorelin

    Clean

    Combined Stack

    Excellent

    Feature

    Side Effects

    CJC-1295 (no DAC)

    Minimal

    CJC-1295 DAC

    GH bleed risk

    Ipamorelin

    Minimal

    Combined Stack

    Minimal

    Feature

    Most Common Use

    CJC-1295 (no DAC)

    Clinical

    CJC-1295 DAC

    Convenience

    Ipamorelin

    Clinical

    Combined Stack

    Gold standard
    Patient ProfilePrimary GoalTypical AgeFit
    Age-related GH declineBody composition, energy, and sleep35–60Excellent
    Athletic recoveryFaster tissue repair and deeper sleep28–50Good
    Metabolic optimizationFat loss and insulin sensitivity30–55Good
    Post-menopausal womenBody composition and bone density support45–65Underserved

    Patient Profile

    Age-related GH decline

    Primary Goal

    Body composition, energy, and sleep

    Typical Age

    35–60

    Fit

    Excellent

    Patient Profile

    Athletic recovery

    Primary Goal

    Faster tissue repair and deeper sleep

    Typical Age

    28–50

    Fit

    Good

    Patient Profile

    Metabolic optimization

    Primary Goal

    Fat loss and insulin sensitivity

    Typical Age

    30–55

    Fit

    Good

    Patient Profile

    Post-menopausal women

    Primary Goal

    Body composition and bone density support

    Typical Age

    45–65

    Fit

    Underserved

    πŸ”¬Women are underserved in peptide therapy

    Most peptide research has been conducted on male subjects. However, women, particularly post-menopausal women, may benefit significantly from GH optimization for body composition, bone density, and sleep quality. A physician can assess whether this protocol is appropriate for your specific hormonal profile.

    ⚠️DAC confusion can be dangerous

    CJC-1295 with DAC and without DAC have drastically different dosing schedules and pharmacokinetics. Confusing the two can lead to sustained GH elevation (GH "bleed") which mimics some risks of exogenous HGH. Always confirm which version your protocol uses.

    Section 03

    How It Works

    The key to understanding this stack is the concept of pulsatility. Your body doesn't release growth hormone in a steady stream. Instead, it releases it in discrete pulses, primarily during deep sleep. This stack amplifies those natural pulses rather than creating an artificial, constant GH elevation.

    🧬Pulsatility: why it matters

    Continuous GH elevation (as seen with exogenous HGH or CJC-1295 with DAC) can downregulate GH receptors over time. Pulsatile release, the kind CJC-1295 (no DAC) + Ipamorelin produces, preserves receptor sensitivity and mimics the body's natural secretion pattern. This is why the no-DAC version is preferred in most clinical protocols.

    βš—οΈWhy Ipamorelin over GHRP-6 or GHRP-2?

    Older secretagogues like GHRP-6 and GHRP-2 trigger GH release but also spike cortisol, prolactin, and hunger via ghrelin receptor activation. Ipamorelin is selective: it stimulates GH release without these side effects, making it the cleanest secretagogue available and the reason it's paired with CJC-1295 in modern protocols.

    Section 04

    Realistic Expectations

    One of the biggest sources of frustration with peptide therapy is unrealistic timelines. Here's what the clinical literature and patient reports actually suggest:

    1

    Week 1

    Improved sleep quality is the most commonly reported early effect. Some patients notice deeper, more restorative sleep within the first few nights. Mild injection-site reactions (redness, warmth) are normal and typically resolve within 20 minutes.
    2

    Week 4

    Increased energy and recovery speed. Some patients report better workout recovery and general vitality. Body composition changes are not yet visible. Injection-site flushing (if present) typically resolves by this point.
    3

    Week 8

    Noticeable improvements in skin elasticity and hydration. Early body composition shifts; patients often report clothes fitting differently before the scale changes. Cognitive clarity improvements are commonly reported.
    4

    Week 12

    Measurable body composition changes: reduced visceral fat, improved lean mass. This is the minimum duration most physicians recommend before evaluating efficacy. Sleep architecture improvements are well-established by this point.
    5

    Month 6

    Full protocol benefits realized. Patients who have adhered to the protocol consistently report the most significant changes. Your physician will evaluate whether to continue, adjust dosing, or transition to a maintenance protocol.

    πŸ“ŠThe evidence gap

    Most published data on CJC-1295/Ipamorelin comes from small studies and clinical observations, not large-scale randomized controlled trials. The timelines above reflect a combination of published literature and aggregated patient reports, not guaranteed outcomes. Your physician will set expectations based on your specific health profile.

    πŸ”„What happens when you stop

    CJC-1295/Ipamorelin stimulates your own GH production; it doesn't replace it. When you discontinue, your GH levels return to baseline over 2 to 4 weeks. There is no "crash" or withdrawal. However, the benefits that depended on elevated GH (sleep quality, body composition maintenance) will gradually diminish without ongoing protocol support.

    Section 05

    Dosing Protocol

    The most common source of confusion (and error) in peptide therapy is the units-to-mcg translation. Here's the standard VitalRx protocol, broken down clearly.

    Month 1: Titration

    10 units = 0.1 mL = 100 mcg each

    100 mcg CJC-1295 + 100 mcg Ipamorelin per injection. One injection nightly, 5 nights per week.

    Draw to the 10-unit mark on a U-100 insulin syringe

    Month 2+: Full Dose

    20 units = 0.2 mL = 200 mcg each

    200 mcg CJC-1295 + 200 mcg Ipamorelin per injection. One injection nightly, 5 nights per week.

    Draw to the 20-unit mark on a U-100 insulin syringe

    ParameterMonth 1Month 2+
    Dose per peptide100 mcg200 mcg
    Syringe draw10 units (0.1 mL)20 units (0.2 mL)
    Frequency5 nights/week5 nights/week
    Timing30 min before bed30 min before bed
    Injection siteSubcutaneous (abdomen)Subcutaneous (abdomen)

    Parameter

    Dose per peptide

    Month 1

    100 mcg

    Month 2+

    200 mcg

    Parameter

    Syringe draw

    Month 1

    10 units (0.1 mL)

    Month 2+

    20 units (0.2 mL)

    Parameter

    Frequency

    Month 1

    5 nights/week

    Month 2+

    5 nights/week

    Parameter

    Timing

    Month 1

    30 min before bed

    Month 2+

    30 min before bed

    Parameter

    Injection site

    Month 1

    Subcutaneous (abdomen)

    Month 2+

    Subcutaneous (abdomen)

    🚫Never double a missed dose

    This is one of the most dangerous mistakes we see in online forums. Doubling up does not "make up" for a missed injection. It risks an unnaturally large GH spike that can cause headaches, water retention, and joint pain. If you miss a dose, simply resume your normal schedule the next evening.

    πŸ’‰VitalRx: pre-constituted eliminates math error

    VitalRx ships pre-constituted vials from our 503B pharmacy. You don't need to reconstitute lyophilized powder, calculate bacteriostatic water ratios, or do any unit math. Draw to the mark your physician specifies. That's it.

    Section 06

    Cycling: Evidence vs. Myth

    "Do I need to cycle CJC/Ipamorelin?" is one of the most common questions. Here's what the evidence actually says:

    ClaimSourceEvidence Level
    Must cycle 8 weeks on / 4 offForum consensusNo human RCT
    5-on / 2-off prevents desensitizationClinical practiceTheoretical
    Continuous use causes receptor downregulationGHRP-6 extrapolationIndirect
    No cycling needed for no-DAC CJC-1295Pharmacokinetic rationalePlausible
    Annual cycling (3 months on, 1 month off)Physician preferenceCommon practice

    Claim

    Must cycle 8 weeks on / 4 off

    Source

    Forum consensus

    Evidence Level

    No human RCT

    Claim

    5-on / 2-off prevents desensitization

    Source

    Clinical practice

    Evidence Level

    Theoretical

    Claim

    Continuous use causes receptor downregulation

    Source

    GHRP-6 extrapolation

    Evidence Level

    Indirect

    Claim

    No cycling needed for no-DAC CJC-1295

    Source

    Pharmacokinetic rationale

    Evidence Level

    Plausible

    Claim

    Annual cycling (3 months on, 1 month off)

    Source

    Physician preference

    Evidence Level

    Common practice

    πŸ“‹The honest answer

    There are no published human randomized controlled trials specifically studying cycling protocols for CJC-1295/Ipamorelin. The 5-on/2-off schedule used by most clinics (including VitalRx) is based on pharmacokinetic reasoning and clinical experience, not hard evidence. Your physician will recommend a cycling approach based on your response to therapy.

    Section 07

    Ready to Inject

    The quality of what you're injecting matters more than anything else in your protocol. Here's how VitalRx approaches preparation and delivery.

    0

    Mixing steps required

    503B

    Pharmacy standard

    2–8Β°C

    Cold-chain shipping

    πŸ“¦Cold-chain + pre-constituted

    VitalRx ships pre-constituted peptides from a 503B outsourcing facility in temperature-controlled packaging. This eliminates reconstitution errors, the #1 source of dosing inaccuracy in at-home peptide therapy. Your vials arrive ready to draw and inject.

    ⚠️Gray-market purity: the data is ugly

    Independent testing of research-grade peptides purchased online has consistently shown alarming results. A 2023 analysis found that only 4.3 out of 10 samples from popular gray-market sources contained the labeled amount of active peptide within acceptable variance. Contaminants, under-dosing, and mislabeling are the norm, not the exception.

    Section 08

    Getting the Most From Your Protocol

    The peptide itself is only part of the equation. These evidence-informed habits can meaningfully impact your results:

    Timing

    Bedtime Alignment

    Inject 30 min before sleep

    GH is released primarily during deep sleep (stages 3–4). Injecting 30 minutes before bed aligns the peptide-induced GH pulse with your body's natural nocturnal secretion window.

    Nutrition

    Fasted Injection Window

    2+ hours after last meal

    Insulin blunts GH release. Eating, especially carbohydrates, within 2 hours of injection can significantly reduce the GH response. Inject on an empty stomach or at least 2 hours post-meal.

    Avoidance

    GH Suppressors

    No alcohol or high-glycemic food

    Alcohol and high-glycemic foods are potent GH suppressors. Even moderate alcohol consumption on injection nights can reduce your GH pulse by 50–75%.

    Schedule

    5-On / 2-Off Rationale

    Receptor sensitivity preservation

    The 2-day break each week is theorized to prevent GH receptor desensitization, though direct human evidence is limited. It also provides practical relief from the daily injection routine.

    Recovery

    Sleep Architecture

    Prioritize sleep hygiene

    If your sleep environment is poor, you're undermining the primary mechanism of action. Consistent sleep schedule, dark room, cool temperature, and limited screen time before bed all amplify protocol effectiveness.

    Mindset

    The 90-Day Rule

    Minimum commitment period

    Body composition changes require time. Most physicians recommend a minimum 90-day commitment before evaluating efficacy. Patients who discontinue at 4–6 weeks often miss the window where measurable changes begin.

    Section 09

    Stacking

    Stacking refers to combining CJC-1295/Ipamorelin with other peptides or compounds. Some combinations are well-supported; others carry meaningful risk.

    Pairs Well With

    • BPC-157β€” Tissue repair and gut healing. Complementary mechanism, no known interaction.
    • Thymosin Beta-4 (TB-500)β€” Systemic tissue repair. Often paired in recovery-focused protocols.
    • MOTS-Cβ€” Mitochondrial peptide. Targets metabolic function via different pathway.
    • NAD+ therapyβ€” Cellular energy. Different mechanism entirely; no competitive interaction.

    Approach with Caution

    • MK-677 (Ibutamoren)β€” Oral GH secretagogue. Can cause sustained GH elevation and insulin resistance with CJC/Ipa.
    • GHRP-6 / GHRP-2β€” Redundant mechanism with more side effects. Cortisol and prolactin spikes.
    • Exogenous HGHβ€” Combining with GH secretagogues can cause supraphysiologic GH levels. Physician assessment required.
    • Multiple GH-axis compoundsβ€” Stacking 3+ GH-targeting compounds increases unpredictability without proportional benefit.

    ⚠️Community stacking behavior

    Online forums frequently recommend aggressive multi-peptide stacks without acknowledging that interaction data between most peptide combinations simply doesn't exist. Physician oversight is especially important when combining compounds, not because we're gatekeeping, but because the safety data isn't there yet.

    Section 10

    Pricing Comparison

    Peptide therapy pricing is notoriously opaque. Here's an honest comparison:

    SourceMonthly CostPhysicianPharmacy GradePurity Verified
    Other telehealth clinics$250–$450/moYesYesVaries
    VitalRx, Month 1$199Yes503BCoA included
    VitalRx, Month 2+$229/moYes503BCoA included
    Gray market (research-grade)$40–$80/moNoNoNo

    Source

    Other telehealth clinics

    Monthly Cost

    $250–$450/mo

    Physician

    Yes

    Pharmacy Grade

    Yes

    Purity Verified

    Varies

    Source

    VitalRx, Month 1

    Monthly Cost

    $199

    Physician

    Yes

    Pharmacy Grade

    503B

    Purity Verified

    CoA included

    Source

    VitalRx, Month 2+

    Monthly Cost

    $229/mo

    Physician

    Yes

    Pharmacy Grade

    503B

    Purity Verified

    CoA included

    Source

    Gray market (research-grade)

    Monthly Cost

    $40–$80/mo

    Physician

    No

    Pharmacy Grade

    No

    Purity Verified

    No

    Included

    Medication

    Pre-constituted CJC-1295 + Ipamorelin from a 503B pharmacy. Ready to inject.

    Included

    Physician Oversight

    Board-certified physician review, prescription, and ongoing protocol support.

    Included

    No Lab Requirement

    We don't require labs to start. Your physician may recommend them based on your health profile.

    Included

    Supplies + Shipping

    Syringes, alcohol wipes, and cold-chain shipping included. No hidden fees.

    πŸ’°The number clinics hide

    Many telehealth peptide clinics advertise low consultation fees but charge separately for the medication, shipping, supplies, and follow-up visits. Always ask for the all-in monthly cost. VitalRx's price includes everything: medication, physician oversight, supplies, and shipping.

    πŸ“‰Why Month 1 is priced lower

    Month 1 uses a titration dose (100 mcg vs. 200 mcg). Less medication = lower cost. We pass that savings to you rather than charging the same price for half the dose. It's that simple.

    Section 12

    Community Q&A

    These are real questions we see repeatedly in patient communities. We've answered them with the same transparency we bring to the rest of this guide.

    Section 13

    The VitalRx Model

    Everything above describes why trust matters. Here's how VitalRx is built to earn it:

    🏭

    503B Sourcing

    Every peptide VitalRx prescribes is compounded by an FDA-registered 503B outsourcing facility β€” the highest standard available for compounded medications. Each batch includes a Certificate of Analysis confirming identity, potency, sterility, and endotoxin levels.
    πŸ“¦

    Pre-Constituted Cold Chain

    Your peptides arrive pre-mixed, ready to inject, shipped in temperature-controlled packaging. No reconstitution math. No bacteriostatic water. No guessing. This eliminates the most common source of dosing error in at-home peptide therapy.
    πŸ‘¨β€βš•οΈ

    Physician Oversight

    Every prescription is reviewed and signed by a licensed, board-certified physician. There is no auto-approval. If your health profile raises concerns, your case is escalated for individual review or you're directed to more appropriate care.
    πŸ‡ΊπŸ‡Έ

    One Price, All 50 States

    VitalRx operates under a telehealth model licensed in all 50 states. Your price includes medication, physician oversight, supplies, and cold-chain shipping. No hidden consultation fees. No separate pharmacy charges. No geographic pricing variations.

    Ready for physician-supervised peptide therapy?

    Start with a free health profile. A licensed physician will review your intake and recommend a protocol built around your goals.

    Get Your Free Consultation β†’

    No subscription required Β· Cancel anytime Β· All 50 states